On ECHEMI
Home > Drugs > Chengdu Huashen Technology Group Co., Ltd. Pharmaceutical Factory
Chengdu Huashen Technology Group Co., Ltd. Pharmaceutical Factory
  • Founded in:

    2001-09-17
  • Country:

    China China
  • Address:

    No. 3, Section 2, Jinhua Road, Southwest Airlines Economic Development Zone, Chengdu
  • Tax NO.:

    915101227323530630
  • Registered Funds:

    -
  • Website:

  • Email:

Related Drugs
Ergan Tuirening Oral Liquid
Artemisia annua, Radix Isatidis, Forsythia suspensa, Chrysanthemum, Bitter almond, Platycodon grandiflorum, Mint, Licorice
Name Description Content CAS NO. Registered Holders
Artemisia annua

0
Isatidis Radix

0
Forsythiae Fructus

0
Chrysanthemum

0
ARMENIACAE SEMEN AMARUM

0
Platycodonis Radix

0
PEPPERMINT

0
DGL

0
Wurenchun Capsules
Wu Ren alcohol extract.
Name Description Content CAS NO. Registered Holders
Wu Ren Alcohol Extract

0
Yinyangsuo
Epimedium extract and Schisandra chinensis extract.
Name Description Content CAS NO. Registered Holders
Epimedium extract powder

0
Schisandra Extract

0
Benzbromarone Capsules
The main ingredient of this product is benzbromarone. Molecular formula: C17H12Br2O3 Molecular weight: 424.09
Name Description Content CAS NO. Registered Holders
Benzbromarone

This product is a benzofuran derivative and a uricosuric drug. Its mechanism of action is mainly to inhibit the reabsorption of uric acid by the renal tubules, thereby reducing the concentration of uric acid in the blood.

More

This product is a benzofuran derivative and a uricosuric drug. Its mechanism of action is mainly to inhibit the reabsorption of uric acid by the renal tubules, thereby reducing the concentration of uric acid in the blood.

3562-84-3 8
Sanqi Tongshu Capsules
Notoginsenotriol saponin
Name Description Content CAS NO. Registered Holders
Panax notoginsenoside

It has a significant protective effect on experimental cerebral ischemia and cerebral infarction animals, and can significantly improve their functional and behavioral disorders. It reduces cerebral vascular resistance and increases blood flow in the internal carotid artery of dogs. It can inhibit the aggregation of rat platelets induced by ADP, AA, and collagen, as well as the aggregation of human platelets induced by ADP, AA, PAF, and thrombin. At the same time, it can reduce the viscosity and hematocrit of rat whole blood and inhibit thrombosis. It also has the effect of improving microcirculation.

More

It has a significant protective effect on experimental cerebral ischemia and cerebral infarction animals, and can significantly improve their functional and behavioral disorders. It reduces cerebral vascular resistance and increases blood flow in the internal carotid artery of dogs. It can inhibit the aggregation of rat platelets induced by ADP, AA, and collagen, as well as the aggregation of human platelets induced by ADP, AA, PAF, and thrombin. At the same time, it can reduce the viscosity and hematocrit of rat whole blood and inhibit thrombosis. It also has the effect of improving microcirculation.

0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.